QNTM – quantum biopharma ltd. - class b subordinate voting shares (US:NASDAQ)
Stock Stats
News
Quantum Biopharma (NASDAQ:QNTM) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Investigative News Program W5 Airs Final Segment on USD $700 Million Stock Market Manipulation Lawsuit of Quantum Biopharma Involving CIBC and RBC [Yahoo! Finance]
Investigative News Program W5 Airs Final Segment on USD $700 Million Stock Market Manipulation Lawsuit of Quantum Biopharma Involving CIBC and RBC
Quantum Biopharma (NASDAQ:QNTM) was upgraded by analysts at Wall Street
REPEAT: Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada's Largest Banks, CIBC and RBC [Yahoo! Finance]
Form 6-K Quantum Biopharma Ltd. For: Dec 01
Form 6-K Quantum Biopharma Ltd. For: Nov 27
Form 6-K Quantum Biopharma Ltd. For: Nov 26
Form 6-K Quantum Biopharma Ltd. For: Nov 25
Form 6-K Quantum Biopharma Ltd. For: Nov 07
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.